Cargando…

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis

BACKGROUND: The impact of Tet oncogene family member 2 (TET2) mutations on the prognosis of acute myeloid leukemia (AML) is still controversial. A meta analysis is needed in order to assess the prognostic significance of TET2 mutation in AML. METHODS: Five databases including PubMed, Cochrane, EMBas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ruiqi, Gao, Xiaoning, Yu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485112/ https://www.ncbi.nlm.nih.gov/pubmed/31023266 http://dx.doi.org/10.1186/s12885-019-5602-8

Ejemplares similares

Expression and prognosis analysis of TET family in acute myeloid leukemia
por: Zhang, Tingjuan, et al.
Publicado: (2020)

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
por: Nabil, Reem, et al.
Publicado: (2022)

Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
por: Stölzel, Friedrich, et al.
Publicado: (2023)

The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia
por: Zhao, YiFan, et al.
Publicado: (2023)

Comprehensively analyze the expression and prognostic role for ten-eleven translocations (TETs) in acute myeloid leukemia
por: Huang, Yan, et al.
Publicado: (2020)

TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
por: Shaikh, Abdul Rehman Khalil, et al.
Publicado: (2021)

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
por: Lara, Joshua J., et al.
Publicado: (2022)

The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia
por: Hamed, Nahla A., et al.
Publicado: (2020)

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2022)

Detection of TET2 Mutation in Patients with De Novo Acute Myeloid Leukemia: A Mutation Analysis of 51 Iranian Patients
por: Chehreghani, Zahra, et al.
Publicado: (2022)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
por: Das, Andrew B., et al.
Publicado: (2019)

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Chen, Wenlan, et al.
Publicado: (2016)

The Prognostic Value of TP53 Mutations in Adult Acute Myeloid Leukemia: A Meta-Analysis
por: Qin, Guoxiang, et al.
Publicado: (2022)

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2017)

Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia
por: Wang, Jingyi, et al.
Publicado: (2020)

Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia
por: Liu, Peng, et al.
Publicado: (2021)

Oncogenic drivers dictate immune control of acute myeloid leukemia
por: Austin, Rebecca J., et al.
Publicado: (2023)

Prognostic significance of Spinster homolog gene family in acute myeloid leukemia
por: Huang, Wenhui, et al.
Publicado: (2020)

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia
por: Lin, Mei-si, et al.
Publicado: (2022)

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)

Detection of FLT3 Oncogene Mutations in Acute Myeloid Leukemia Using Conformation Sensitive Gel Electrophoresis
por: Gari, Mamdooh, et al.
Publicado: (2008)

TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population
por: Yao, Hongxia, et al.
Publicado: (2017)

Role of NR4A family members in myeloid cells and leukemia
por: Boulet, Salix, et al.
Publicado: (2022)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation
por: Brendel, Cornelia, et al.
Publicado: (2015)

MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia
por: Frech, Miriam, et al.
Publicado: (2018)

Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis
por: Al-Bulushi, Fatma, et al.
Publicado: (2022)

Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family
por: Qiu, Qunxiang, et al.
Publicado: (2021)

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2022)

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
por: Fobare, Sydney, et al.
Publicado: (2022)

Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
por: Dao, Feng-Ting, et al.
Publicado: (2021)

Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia
por: Larrue, Clément, et al.
Publicado: (2019)

Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2018)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
por: Oñate, Guadalupe, et al.
Publicado: (2022)

Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family
por: Wafa, Abdulsamad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lob2crhgfuq1ri325j9gudbjl7